Reflections: A look back at the 2025 NDARC Annual Research Symposium
Chair of the 2025 Scientific Program Committee, Dr Peter Gates, reflects on a day of shared learning and collaboration.
Chair of the 2025 Scientific Program Committee, Dr Peter Gates, reflects on a day of shared learning and collaboration.
I had the privilege of once again chairing the Scientific Program Committee (SPC) for the 2025 NDARC Annual Research Symposium, which took place at Wesley Conference Centre in Sydney on Friday, 26 September. This year, we received 25 abstract submissions – each a testament to the ongoing commitment of NDARC staff to addressing substance-related harms through rigorous, policy-relevant research. It was a true showcase of the breadth and depth of work being conducted across the Centre.
National Drug Strategy panel discussion
A major highlight of this year’s Symposium was our first-ever plenary panel: a dynamic and engaging session chaired by journalist and physician, Dr Norman Swan. His skilled moderation drew out thoughtful reflections and spirited discussion from our esteemed panellists: Associate Professor Robert Ali, a public health physician and specialist in addiction medicine; Professor Mel Miller, Chair of the NDARC Advisory Board; Dr Mary Harrod, Chief Executive of NSW Users and AIDS Association (NUAA); and Associate Professor Michael Doyle, who leads First Nations health research at the Edith Collins Centre, Sydney Medical School at the University of Sydney.
The panel focused on the National Drug Strategy, exploring its successes and shortcomings with candour and insight. The success of this format added a new dimension to the Symposium, and may well inspire future events to continue experimenting with engaging formats.
Esteemed international keynote speakers
We were also honoured to host two keynote speakers. Professor Sharon Hutchinson from Glasgow Caledonian University delivered a compelling presentation on evidence-based approaches to eliminating hepatitis C and reducing drug-related harms in Scotland.
Later in the day, Professor Steve Shoptaw from UCLA shared his expertise on methamphetamine use and treatment, offering both clinical and community perspectives.
Shining a spotlight on NDARC staff contributions
As always, the Symposium centred on showcasing the work of NDARC staff. Standout presentations included Associate Professor Amy Peacock’s insights on alcohol price policy and Associate Professor Ryan Courtney, who revealed the much-anticipated results of his trial comparing vaping with nicotine replacement therapy for smoking cessation.
Three breakout sessions fostered rich discussion and highlighted the collaborative spirit that underpins NDARC’s work. I wish I could have attended all three (you can watch recordings online), but thoroughly enjoyed the session on NDARC collaborations. It was inspiring to see our work reaching the community, and the enthusiasm of attendees reflected the relevance and impact of the research presented.
An opportunity to connect
Another personal highlight was the audience. This year, we welcomed 208 in-person attendees and 237 who joined us via livestream. The diversity among participants was remarkable: students, researchers, clinicians, health professionals, harm reduction workers, psychologists, counsellors and individuals from the justice system all came together. It was an incredible turnout and a valuable opportunity for connection, collaboration and relationship-building.
My sincere thanks go to all presenters and chairs, as well as the NDARC professional staff who ensured the day ran smoothly. They did an outstanding job bringing the event together, and their tireless efforts made this year such a success.
In closing, the Symposium continues to be a vital space for sharing knowledge, sparking ideas and strengthening connections across research, policy and practice.
View recordings of the day’s sessions, poster presentations and more on our website.